- Report
- January 2025
- 175 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- July 2025
- 396 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 566 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 273 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 471 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 250 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 697 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 198 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- January 2025
- 180 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- January 2025
- 183 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- April 2025
- 200 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- June 2025
- 190 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- April 2025
- 186 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- January 2025
- 180 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- August 2024
- 200 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- July 2024
- 158 Pages
Global
From €3766EUR$4,250USD£3,243GBP
- Report
- July 2024
- 156 Pages
Global
From €3766EUR$4,250USD£3,243GBP
- Report
- April 2025
- 79 Pages
Global
From €8857EUR$9,995USD£7,628GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more